• GENENTECH INC Analyst Recommendations

  • Analyst Consensus: DNA

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.115 Buy 26
    30 Days Ago 2.115 Buy 26
    60 Days Ago 2.000 Buy 28
    90 Days Ago 2.100 Buy 30
    120 Days Ago 2.067 Buy 30

  • Analyst Ratings: DNA

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Citigroup Buy Hold 08/15/2008 108.00
    Deutsche Securities — Buy 07/25/2008 97.00
    RBC Capital Mkts — Outperform 07/25/2008 100.00
    UBS — Buy 07/22/2008 105.00
    RBC Capital Mkts — Outperform 07/22/2008 95.00
    Piper Jaffray Buy Neutral 07/22/2008 —
    Lehman Brothers Equal-Weight Overweight 07/21/2008 —
    Citigroup — Buy 07/17/2008 91.00
    Lazard Capital — Buy 07/15/2008 90.00
    Friedman Billings Mkt Perform — 07/10/2008 —
    Friedman Billings Mkt Perform — 06/30/2008 —
    Deutsche Securities — Buy 06/19/2008 83.00
    Caris & Company Buy — 03/13/2008 —
    UBS — Buy 02/25/2008 95.00
    Lazard Capital — Buy 02/25/2008 87.00
    Lehman Brothers — Equal-weight 02/25/2008 70.00
    RBC Capital Mkts — Outperform 02/25/2008 84.00
    Caris & Company — Buy 02/25/2008 91.00
    Jefferies & Co — Hold 02/25/2008 78.00
    Friedman Billings — Mkt Perform 02/25/2008 76.00
    Rodman & Renshaw Mkt Perform Mkt Outperform 02/25/2008 90.00
    UBS — Buy 02/13/2008 93.00
    Broadpoint Capital — Buy 01/15/2008 76.00
    Friedman Billings — Mkt Perform 01/04/2008 67.00
    Lehman Brothers — Equal-weight 12/06/2007 64.00
    Broadpoint Capital — Buy 12/06/2007 82.00
    UBS — Buy 12/06/2007 94.00
    RBC Capital Mkts — Outperform 12/06/2007 80.00
    Leerink Swann Outperform Mkt Perform 12/06/2007 —
    BMO Capital Markets — Market Perform 12/06/2007 74.00
    Next